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Purpose: To isolate and identify an antibiotic produced by a soil bacterium, Intrasporangium strain N8, 
with antibacterial activity against both Gram-positive and Gram-negative bacteria.  
Methods: Fermentation followed by extraction using a three-solvent system (petroleum ether, acetone 
and ethyl acetate) and pH precipitation, successfully separated the antibiotic complex from the culture 
broth. Purification was carried out using flash column chromatography (FCC), thin-layer chromatography 
(TLC) and reverse phase high performance liquid chromatography (HPLC). The identities of the 
molecules were elucidated by gas chromatography-mass spectrometry (GC-MS) analysis.  
Results: Three main components of the antibiotic were isolated and identified as 4-methyl-3-penten-2-
one, 4-hydroxy-4-methyl-2-pentanone and N-acetyltryptamine. Bioassay results showed activity against 
both mammalian and plant pathogenic bacteria including Pseudomonas fluorescens, Xanthomonas 
campestris pv campestris, Escherichia coli and Serratia marcescens. Pseudomonas fluorescens (MIC = 
0.0625 μg/ml) and Xanthomonas campestris pv campestris (MIC = 0.0026 μg/ml) represent the two 
plant pathogenic genera that are notoriously difficult to contain in the field.  
Conclusions: Since the antibiotic isolated during this study showed activity against both mammalian 
and plant pathogenic bacteria, it is hoped that this work will encourage further investigation in this field. 
This antibiotic could become very useful as an agricultural bacteriocide against some resistant plant 
pathogens. 
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INTRODUCTION 
 
Natural microbial products are the origin of 
most of the antibiotics in the market today. 
However, research on antibiotics and natural 
products has declined significantly during the 
last decade as a consequence of many 
factors, chief among which are the lack of 
interest in the field due to strong competition 
from synthetic compounds as sources of 
drugs [1]. There is also the ever expanding 
problem of bacterial resistance [2]. 
Consequently, there is an alarming scarcity of 
new antibiotic classes in the pipelines of the 
pharmaceutical industry. The above notwith-
standing, microbial natural products remain 
the most promising sources of novel 
antibiotics [3], although new approaches are 
required to improve the efficiency of the 
discovery process. The choice of best 
approach at the screening phase and the 
challenges faced during the isolation, 
purification and identification of the active 
compounds are critical factors to success in 
this area.  
 
In our approach, we have recognized that 
antibiotic compounds are in two main forms - 
a salt form which is soluble in hydrophilic 
solvents and a basic form which is insoluble 
in these solvents. Therefore, a careful choice 
of solvent system provides an efficient and 
faster route to direct extraction of antibiotic 
compounds from complex mixtures [4]. These 
compounds can be identified by combinations 
of very powerful analytical tools that take 
advantage of their individual strengths. The 
first combination is gas chromatography-
mass spectroscopy (GC-MS) followed by gas 
chromatography-Fourier transform infrared 
(GC-FITR) and the second, HPLC-MS. 
Researchers are obtaining more information 
about their samples at a faster rate than was 
previously possible [5]. 
 
In this study, our aim was to isolate and 
identify an antimicrobial substance produced 
by Intrasporangium strain N8 using GC-MS 
analysis. Gas chromatography-mass spectro-
scopy (GC-MS) is the single most important 
tool for the identification and quantification of 
volatile and semi-volatile compounds in 
complex mixtures [6]. This study represents a 
part of the global search for new antibiotic 
compounds as organisms with multiple drug 
resistance continue to be a threat to public 






Strain N8 was isolated from a barnyard soil in 
the KwaZulu-Natal midlands, South Africa, in 
a massive actinomycetes-screening program-
me that led to the isolation of approximately 
2600 strains [8]. Stock cultures were kept on 
agar slants or stored frozen in glycerol at 
minus 80 oC. Identification of N8 to genus 
level was carried out according to Bergey’s 
Manual of Determinative Bacteriology [9] and 
involved morphological, physiological, and 




A mature slant culture of N8 was inoculated 
into a 250 ml Erlenmeyer flask containing 
100ml of seed medium, viz: Nutrient broth 
(NB) [meat extract 1g/L, yeast extract 2 g/L, 
peptone 5 g/L and sodium chloride 8.0 g/L, 
pH 7.1 after sterilization]. The culture was 
incubated on a rotary shaker (250 rpm) at 30 
oC for 48 h. Ten millilitres of this seed culture 
were transferred into a 250 ml flask 
containing 200 ml of the same medium with 
5.0 g glycerol (Panreac, Barcelona, Spain) 
added. Shake-flask fermentation was carried 
out at 30 oC for 10 days under agitation at 
250 rpm. Antibiotic production was monitored 
every 12 h by bioassay which included 
measuring the diameter of inhibition zones on 
plates containing test organisms.  
 
One hundred 250 ml flasks each containing 
100 ml of medium were used to obtain a total 
of approximately 10 L of strain N8 culture 
broth. The culture was centrifuged for 15 min 
at 9000 x g and the supernatant filtered 
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through Cameo 25 AS acetate membrane 
filters prior to analysis. 
 
Isolation of the antibiotic 
 
Three solvents namely, petroleum ether, 
acetone and ethyl acetate, were used for the 
recovery of the antibiotic from the broth. A 
ratio of 1:1 solvent: broth was used and the 
extraction procedure was repeated three 
times. The first solvent, petroleum ether (PE), 
was added to the cell-free broth, the mixture 
shaken thoroughly and left overnight to settle. 
Separation of the organic and aqueous layers 
was achieved by means of a separating 
funnel. The PE extract was tested for 
antimicrobial activity before being discarded. 
The second solvent, acetone, was added to 
the aqueous layer and the resultant 
precipitate removed by centrifugation at 
9000xg for 15 minutes. This precipitate too 
was tested for antimicrobial activity by the 
agar disk-diffusion method [10] following 
dissolution in methanol (10ml). The remaining 
solution was concentrated 10-fold with a 
Buchi rotary evaporator at 30oC. Finally, the 
solution was extracted with an equal volume 
of ethyl acetate (1:1). 
 
The aqueous layer was further extracted by 
adjusting the pH to 3 and 8.2 with 2M HCL 
and 2M NaOH respectively, and allowing the 
mixture to crystallize overnight at 4oC. The 
crystals were recovered by filtering through 
Whatman’s glass microfiber and dried 
overnight at ambient temperature. Two 
bioassay methods, agar well- and agar disk-
diffusion, were used to monitor the 
antimicrobial activity of the extracts. These 
procedures allowed efficient extraction of the 
antibiotic complex from the culture broth. 
 
Purification by chromatography 
 
Having established that the antibacterial 
agent resided in the ethyl acetate extract, 
various chromatographic techniques were 
used to further purify it. Flash column 
chromatography (FCC) followed by thin layer 
chromatography (TLC) was carried out on 
each solvent extract using coated Merck 
Kieselgel 60 F254 plastic sheets. Thin layer 
chromatography plates were visualized by 
first checking for fluorescence under 
ultraviolet (UV) light at 254 nm followed by 
staining with anisaldehyde before drying with 
a heat gun. The active material was 
recovered from the TLC plates by excising 
UV fluorescent bands from the chroma-
togram, packing the material into a Pasteur 
pipette and eluting through glass wool using 
ethyl acetate as eluate. All the preparations 
were further concentrated in a Buchi 
Rotavapor EL 130 at 30 oC before testing for 
biological activity. A further purification step 
was also carried out on each solvent extract 
using the Harrison research chromatotron 
technique. Care was taken not to increase 
the concentration of methanol beyond 50 % 
because of its tendency to dissolve the silica 
gel on the chromatotron plates. Fractions 
collected at 1min intervals were pooled, and 
spotted onto TLC plates. The positions of the 
spots were detected under UV light or by 
staining with anisaldehyde. Corresponding 
positions on duplicate plates were excised, 
eluted and tested for antimicrobial activity. 
 
Further purification was carried out by 
reverse phase high performance liquid 
chromatography (HPLC) and isocratic HPLC 
analysis was conducted on the ethyl acetate 
extract using a Data Apex Clarity 
chromatography station equipped with an 
Alltech C-18 reverse phase column and 
monitored by absorbance at 280nm. 
Separations using a gradient system were 
performed on a Varian Analytical Instruments 
HPLC equipped with a Thermo Separation 
Products automated fraction collector. Fifty 
microlitres of the extract were injected into a 
Hypersil 5 ODS analytical column (25 cm x 
10 mm) followed by gradient elution in 
decreasing concentrations of methanol (80% 
- 50%) in water. Absorbance was measured 
using a UV detector (UV6000LP, Thermo 
Finnigan) at 280 nm. 
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Identification of the antibiotic 
 
Gas chromatography-mass spectroscopic 
(GC-MS) analysis of the compound showing 
antibiotic activity was carried out. Mass 
spectra were recorded on a ThermoFinnigan 
Polaris/ QCQ Plus instrument coupled to a 
Varian CP-3800 gas chromatograph. Low 
and high resolution mass spectra were 
measured on a Kratos MS 80 RF double 
focusing magnetic sector instrument at 70 
eV. Spectra were obtained using both an 
electron impact mode (EI) and a chemical 
ionization mode (CI). The MS profile of the 
antimicrobial substance produced by strain 
N8 was compared to MS profiles from the 




The antimicrobial activity of the active 
compound was determined in vitro by agar 
disk diffusion or micro-dilution methods in 
terms of minimum inhibitory concentration 
(MIC) according to the protocol 
recommended by the Clinical and Laboratory 
Standards Institute (CLSI) [formerly National 
committee for Clinical Laboratory Standards 
(NCCLS) [10]. The test organisms used were 
Escherichia coli, Staphylococcus aureus, 
Pseudomonas fluorescens, Serratia 
marcescens, Enteroococcus faecalis, 
Candida utilis and Xanthomonas campestris 
pv campestris, all from the culture collection 
in the Department of Microbiology, University 
of KwaZulu-Natal (UKZN), South Africa. The 
above organisms were selected on the basis 
of a 1999 survey of major human and plant 
pathogens prevalent in KwaZulu-Natal 
hospitals and the University vegetable 
garden. All test organisms were stored on 





A one-way analysis of variance model was 
used to compare the average inhibition zone 
diameter (AIZD) recorded for the seven test 
organisms in a triplicate experiment. 
Statistical analysis of the data was carried out 
using SPSS (version 11.5). Mean and 
standard deviation were computed for each 
of the organisms. The differences were noted 
on the basis of an F-test, and the 
corresponding p-value, at a 5 % level of 
significance. Fisher’s least significant 
difference method was used to determine the 





An earlier report on strain N8 using 
morphological, physiological and biochemical 
characterization identified the organism as an 
Intrasporangium species (Fig 1) [8]. During 
fermentation, maximum yield of the antibiotic 
was obtained after 7 days incubation. 
Optimum antibiotic yield was obtained at 
neutral pH and an incubation temperature of 
30 oC. 
     
 
Fig 1: Scanning electron micrograph of 
Intrasporangium strain N8 mycelium (arrow shows 
oval shaped spores exposed inside a broken 
vesicle). 
 
The use of three solvents (petroleum ether, 
acetone and ethyl acetate) during extraction, 
together with pH precipitation, successfully 
isolated the antibiotic from the broth. 
Separation of the organic and aqueous layers 
was easily achieved using a separating 
funnel. The organic layer when dried with 
anhydrous NaCl and evaporated to near 
dryness produced a yellow liquid with some 
yellow crystals present on the sides of the 
flask after cooling to 25 oC. Bioassay results  
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Fig 2: Gas chromatogram of the antimicrobial substance in the ethyl acetate extract after extraction of the culture fluid of 
strain N8. Components A – D were subjected to mass spectroscopy analysis. Note the occurrence of a possible 
tryptamine structure (D) which, is essential for antimicrobial activity [15, 16]. 
 
for the three solvent extracts showed clear 
inhibition of  Escherichia  coli  with clear 
zones around the paper disks dipped in the 
ethyl acetate extract (EAF). Large inhibition 
zones (30 mm diameter) were also observed 
for the acetone extract (AH), but these were 
cloudy, unlike the very clear zones produced 
by the EAF (21 mm diameter). No zone of 
inhibition occurred with the petroleum ether 
extract (PE). 
 
Gas chromatography-mass spectroscopic 
(GC-MS) data analysis of the EAF indicated 
that the antibiotic comprised four main 
components labeled A – D (Fig 2). These 
components separated by gas chromato-
graphy (GC) were then subjected to mass 
spectrum analysis and their retention indices 
compared to computer database listings of 
known compounds (11). 
 
The compounds detected by GC-MS had 
their molecular formulae elucidated as: 
C6H10O (A – B = 4-methyl-3-penten-2-one); 
C6H12O2 (C = 4-hydroxy-4-methyl-2-penta-
none); and C12H14N2O (D = N-[2-(1H-indol-3-
yl)ethylacetamide), as shown in Table 1. The 
closest matching structure from the computer 
database of known compounds was found for 
C12H14N2O (D) with 71 % probability. 
 
Analyses of the GC-MS data suggested that 
components A and B are similar compounds 
since they have the same molecular weight 
and formula. Their different retention indices 
strongly suggest that they are probably 
isomers. Thus a total of three main 
compounds were detected by GC. In GC 
application, the lighter molecules elute first 
followed by the heavier ones [12]. Therefore, 
of the main compounds separated by the GC, 
component D was the heaviest molecule 
since it eluted last from the column. It has an 
MS spectrum that closely resembles (71%) 
that of an indolethylacetamide (= N-
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Table 1: Compounds identified* by mass spectroscopic data analysis following gas chromatographic 











Index name of compound Prob. 
(%) 
A 6.93 98 C6H10O  4 methyl-4-penten-2-one 37 
B 8.06 98 C6H10O  4 methyl-3-penten-2-one 39 
C 8.99 116 C6H12O2  4-hydroxy-4-methyl-2-pentanone 57 
D 24.30 202 C12H14N2O  N-[2-(1H-indol-3-yl)ethyl acetamide 71 








































Fig 3: Structural identity of component D: (A) full mass spectrum of component D; (B) matching (71 %) full 
mass spectrum of N-(2-(1H-indol-3-yl)ethylacetamide (=N-acetyltryptamine).  
The 71 % probability reflects how closely the spectrum of the compound matched the index value obtained from a 
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Table 2: Antimicrobial activity of the antibiotic produced by Intrasporangium strain N8 against test 
organisms 
 
Test organism Extent of 
inhibition 




Staphylococcus aureus + 10.0±1.00 0.0078±0.000 
Escherichia coli +++ 25.0±0.58 0.0039±0.000 
Streptococcus faecalis ++ 20.0±0.00 0.0625±0.000 
Serratia marcescens ++ 15.0±1.16 0.1250±0.000 
Pseudomonas fluorescens ++++ 26.0±1.00 0.2500±0.000 
Candida utilis ++ 21.0±1.53 0.0020±0.000 












 * Screening on Mueller Hinton (MH) agar, ^screening in MH broth; + = positive inhibition (3–10 mm); ++ = 11–20mm; 
+++ = 21–25mm; ++++ = 26–30mm. 
 
Further bioassay experiments showed that 
component D was responsible for the 
observed antibiotic activity. It showed good 
antimicrobial activity against all the test 
organisms used, especially against 
Pseudomonas fluorescens and Xanthomonas 
campestris pv campestris, with MICs of 
0.0625 µg/ml and 0.0026 µg/ ml, respectively. 
Its spectrum of activity included both gram-
negative and gram-positive bacteria and the 
yeast Candida utilis (Table 2). 
 
We observed a significant difference in 
average inhibition zone diameters between 
the test organisms, F(6, 14) = 130.351, p < 
0.001. At 5% level, the mean AIZD for 
Xanthomonas campestris pv campestris was 
significantly greater than that for all the other 
organisms except Pseudomonas fluorescens. 
All other AIZD were significantly different 
except for Candida utilis and Streptococcus 
faecalis, t(14) = 0.667, p = 0.405 and 
Escherichia coli and Pseudomonas 




Most secondary metabolites, including 
antibiotics, are usually produced at a very 
late stage during the growth of an organism 
[13]. On this assumption, antibiotic production 
in the growth medium was monitored every 
12 h over the fermentation period to establish 
the time of maximum yield. The growth curve 
of strain N8 indicates that the organism 
should be grown for 7 to 10 days in a simple 
medium before harvesting the broth for 
antibiotic analysis. In this study, harvesting of 
the secondary metabolite was done on the 
tenth day, allowing time for the stationary 
phase to be reached at which time a higher 
yield was available. 
 
The solvent extraction procedure used 
enhanced the separation of compounds of 
different polarities. Hydrophilic organic 
substances in the broth were targeted and 
extracted with polar solvents while the 
hydrophobic ones were solubilized in the 
non-polar solvents used. The non-polar 
solvent, petroleum ether, was used to remove 
lipids from the broth. Acetone precipitation 
helped to remove most solutes, especially 
protein, from the broth and ethyl acetate was 
used for extracting the remaining polar 
organic substances. The extraction profile 
suggested that the antibacterial agent 
produced by strain N8, is a polar organic 
compound because of its solubility in polar 
organic solvents, and not a lipid due to its 
insolubility in the non-polar solvent petroleum 
ether. The polar nature of the active 
substance was confirmed when the 
petroleum ether extract failed to show any 
biological activity against E. coli. This 
preliminary result was an important step in 
this investigation as the majority of antibiotics 
are polar [14]. 
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The successful extraction of the antimicrobial 
agent from the broth with ethyl acetate and 
other polar solvents led us to focus on the 
ethyl acetate fraction (EAF) in subsequent 
work. We found important issues to be choice 
of growth media; solvents used; and a 
continuous monitoring of biological activity. 
Stringent controls are essential during 
bioassays and care must be taken to avoid 
erroneous results; for example freeze drying 
samples before bioassay may concentrate 
various constituents of the culture medium 
giving rise to false positive results. Also the 
media used for bioassay must be able to 
support vigorous growth of the test organism 
in the absence of potentially inhibitory 
compounds. If possible, complex media 
should be avoided; the simpler the medium 
the better. 
 
Attempts were made to assign a chemical 
structure to the antibiotic produced by strain 
N8 using all the data available. The 
indications are that it is a tryptamine, the 
chemical structure of which is postulated to 










Fig 4: Chemical structure of antibiotic produced by 
Intrasporangium strain N8 
 
N-acetyltryptamine is reported to be 
produced by Thermoactinomyces strain 
TA66-2 [15] and Streptomyces species strain 
TN58 [16]. These authors also reported that 
thiazole was produced simultaneously with N-
acetyltryptamine. Tryptamine is a monoamine 
alkaloid found in plants, fungi, and animals 
and the backbone structure of a group of 
compounds known collectively as tryptamines 
[17]. This group includes many biologically 
active compounds, including neurotrans-
mitters and psychedelic drugs [18]. 
Tryptamine is also found in trace amounts in 
the brains of mammals and is believed to 
play a role as a neuromodulator or 
neurotransmitter. Structurally, it is based on 
the indole ring, and is chemically related to 
the amino acid tryptophan, from which its 
name is derived [17]. A closely related 
structure to tryptamine is melatonin (Fig 5) 
which has been associated with the ability to 
inhibit tumour growth in vivo and in vitro. 





Fig 5: Chemical structure of melatonin 
 
Some tryptamine-based antibiotics have also 
been reported. An example is, nematophin 
(3-indoleethyl (3′-methyl-2′-oxo)pentane-
mide), isolated from Xenorhabdus 
nematophilus[[19]. The natural compound 
showed strong in vitro bioactivity against a 
series of fungal and bacterial species [19]. 
Other derivatives of this compound, including 
alkyl- and aryl-substitutions at the 1-position, 
gave elevated antimicrobial activity [20]. The 
same study found that the amide (NH) group 
in the nematophin structure is essential for 
bioactivity. In another published study, it was 
reported that the 2-phenyl derivative of 
nematophin exhibited exceptional activity 
against methicillin-resistant Staphylococcus 
aureus, whereas the isosteric benzimidazole 




The antibiotic produced by Intrasporangium 
strain N8 actively inhibited the growth of all 
the test organisms used, especially that of 
Pseudomonas fluorescens and Xanthomonas 
campestris pv campestris, with MIC of 0.0625 
and 0.0026 μg/ ml, respectively. Members of 
these plant pathogenic genera are difficult to 
contain in the field and N8 might thus prove 
useful as a biocontrol agent. Our results 
showed that strain N8 produces an antibiotic 
that is readily soluble in acetone, ethyl 
acetate and methanol, but insoluble in 
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petroleum ether. It is a polar compound, very 
stable in water and could thus be easily 
formulated as an agricultural bactericide. It is 
also heat stable and passed undamaged 
through the gas chromatograph. An important 
feature of the compound is the presence of a 
tryptamine related structural component 
which is essential for antimicrobial activity. It 
is postulated that the antibiotic produced by 
Intrasporangium strain N8 has the same or a 
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